Preclinical data indicate that micro-dystrophin gene transfer using adeno-associated virus (AAV) can significantly reduce muscle pathology, improve skeletal and cardiac function, and enhance survival in various animal models of DMD [57,58]. Here, DMD is linked to Duchenne muscular dystrophy.